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Chartier-Harlin  and  colleagues  [2]  recently  reported  mutations  in  the eukaryotic  translation  initiation
factor  4-gamma  (EIF4G1)  gene  in  families  with  parkinsonism.  Large-scale  screening  found  two  mutations
(p.R1205H  and p.A502V)  only  in affected  individuals,  although  their relative  frequency  was  very  low.
The  aim of this  study  was  to investigate  EIF4G1  parkinsonism-related  variants  in  two  separate  cohorts
and  study  coding  variability  across  the  gene.  We  ﬁrst  screened  a series  of  familial  Parkinson’s  Disease
(PD)  patients  in  an  attempt  to conﬁrm  previous  results  by  showing  segregation.  Then, to determine  the
extent  of  coding  variation  in the  gene,  we ﬁrst  screened  a  cohort  of sub-Saharan  African  individuals  from
the  Centre  d’Etude  du  Polymorphisme  Humain  – Human  Genome  Diversity  Cell  Line  Panel  (HGDP) [1]
and  then  analyzed  data  from  5350  individuals  National  Heart,  Lung,  and  Blood  Institute  (NHLBI)  exome
sequencing  project.  We  failed  to  identify  any  PD-related  mutations  in  the  familial  samples.  Conversely  we
found  the  p.A502V  variant  in the  NHLBI  population.  We  observed  a high  number  of  coding  polymorphism
in  the  exons  where  the two  PD  variants  have  been  previously  reported.  We  conclude  that  either  EIF4G1
variants  are  an  extremely  rare  cause  of  familial  PD  in Caucasian  cohorts,  or that  A502V  is in  fact  a  rare
benign  variant  not  involved  in PD  aetiology.  Our data  also  suggests  that the  protein  can tolerate  some
extent  of  variability  particularly  at this  point  of  the  gene.ecently, a new gene (EIF4G1) has been identiﬁed in one family
ith autosomal dominant late-onset Parkinson’s Disease [2]. Link-
ge was ascribed to a region at chromosome 3q26–28 containing
pproximately 159 genes. Sequence analysis found only one novel
oding variant (p.R1205H in the EIF4G1 gene) which segregated
ith disease, which was  absent in 4050 controls and which was
volutionary conserved in mammals. Screening a cohort of about
800 PD cases (familial and sporadic) identiﬁed nine additional
atients of the p.R1205H mutation. Further molecular analysis of
he EIF4G1 gene in a large case–control cohort (4500 cases and 3800
ontrols) identiﬁed another novel missense mutation (p.A502V) in
hree PD individuals, which was not found in controls. These data
ndicate that these variants are extremely rare in the PD popu-
ation (0.2% for p.R1205H and 0.06% for p.A502V). Assignment of
athogenicity can be difﬁcult when variants are very rare. With this
ackground, we screened 150 familial PD cases from our UK familial
arkinson’s Disease series, in which we have previously identi-
ed LRRK2, VPS35 and SNCA mutations [5,7] in order to determine
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whether we could provide further that this gene is indeed a PD-
related locus. We also assessed these coding positions in a set
of African samples (Table 1) from the Human Diversity series –
a standard panel of African samples [1], as African samples have
the greatest diversity and offer a rapid route to the identiﬁcation
of benign polymorphisms [4]. Brieﬂy, exon 8 and exon 22 of the
EIF4G1 gene (NM 182917.3) were PCR ampliﬁed and sequenced in
the two  cohorts for a total of 114 African samples and 150 familial
PD cases.
To  obtain a more exhaustive description of the pattern
of variability in that gene we also extracted genotype data
from the NHLBI exome sequencing project (Exome Vari-
ant Server, NHLBI Exome Sequencing Project (ESP), Seattle,
WA (http://evs.gs.washington.edu/EVS/)  [January 2011], which
includes exome data for 3500 American individuals of European
descent and 1850 African American. Frequencies were computed
using VCFtools. We  used the software ANNOVAR [8] to annotate
the function of the variants.
We  failed to identify any mutation previously reported to be
associated with PD our familial cohort, but we identiﬁed one coding
Open access under CC BY license.change (P486S) in two PD individuals. The P486S variant is reported
in dbSNP (rs112545306). Interestingly it has been observed in
African-Americans (http://snp.gs.washington.edu/EVS),  with a fre-
quency of 0.15%.
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Table 1
Number of African samples studied per population and geographic regions.
No. of samples Population Geographic origin
35 Biaka Pygmy Central African Republic
15 Mbuti  Pygmy Democratic Republic of Congo
12 Bantu  N.E. Kenya
7 San Namibia
T
E
T
E26 Yoruba Nigeria
24 Mandenka Senegal
8 Bantu S.E. Pedi South Africa
able 2
IF4G1 coding variant detected in the African cohort (NM 182917.4).
Nucleotide change Protein change SNP accession number Fr
c.870G>A M290I rs144947145 0
c.913C>T  R305C rs116508885 0
c.932A>G  Y311C rs16858632 0
c.1145C>T  P382L NA 0
c.1429G>A  E477K rs145228718 0
c.3918G>A R1216H rs34086109 0
able 3
IF4G1 coding variants present in NHLBI Exome Sequencing Project (NM 182917.4). EA =
Nucleotide change Protein change SNP accession number
c.C71T P24L 
c.C167G  A56G 
c.C211T P71S rs113810947
c.282C>G  I94M 
c.451C>G  V151L 
c.481A>G  A161T rs13319149 
C.602G>A  R201H rs34838305 
C.608C>T  A203V 
C.704G>A  R235Q rs144543953 
C.731G>A R244Q rs147855566 
C.779C>T  S260L 
c.821C>T P274L  rs139626338 
c.870G>A  M290I rs144947145 
c.913C>T  R305C rs116508885 
c.914G>A R205H rs151151194
c.926A>G  E309G 
c.932A>G Y311C  rs16858632 
c.1001A>C  P334Q 
c.1013C>T  S338F rs139021806 
c.1036C>A  Q346K 
c.1054G>T  A352S 
c.1063A>G  T355A 
c.1064C>T  T355I 
c.1142C>G  A381G rs142095694 
c.1256G>T  S419I rs138207269 
c.1294A>G  M432V rs2178403 
c.1298C>T  A433V rs145998921 
c.1309A>G  I437V rs144222028 
c.1316C>A  S439Y rs148709174 
c.1331C>T  T444M rs143014570 
c.1352C>A  P451Q rs147419996 
c.1429G>A E477K  rs145228718 
c.1456C>T  P486S rs112545306 
c.1505C>T  A502V rs111290936 
c.1610C>T  A537V 
c.1648G>C  A550P rs111924994 
c.1679G>A G560D rs149685875
c.1696C>T  R566C rs145521479 
c.1700C>A  P567H rs140212150 
c.1754A>C  E585A 
c.1801T>C  W601R rs145247318 
c.1831C>T  R611C 
c.1980A>G  I660M 
c.1982A>G  N661S rs145780534 
c.2096G>C G699A  
c.2114C>G  S705C rs141054452 
c.2152G>C A718P  rs111396765 
c.2225C>T T742M rs147678593 tters 518 (2012) 19– 22
We  identiﬁed six non-synonymous changes in exon 8
and in exon 22 in the African individuals. Of  these, one
is a novel change (P382L), the others are variants recently
reported in dbSNP and found mainly in African populations
(http://snp.gs.washington.edu/EVS). To predict the impact on pro-
tein function of these non-synonymous variants, we performed an
in silico analysis using the software PolyPhen and SIFT [6] and all
were predicted to be benign (Table 2).
Analysis of the NHLBI samples allowed us to detect the
A502V variant in two  European-American individuals (frequency
of 0.02%). We identiﬁed 95 nonsynonymous SNP over 32 exons
equency Population Effect (SIFT)
.01 San, Bantu SE Tolerated
.01 Youruba Tolerated
.03 Bantu SW,  Bantu NE, Yoruba, Mandenka Tolerated
.004 San Tolerated
.004 Mandenka Tolerated
.004 Biaka Pygmy Tolerated
 European American population. AA = African American population.
 Frequency (EA) Frequency (AA) Exon
0.000142 0 2
0.000142 0 3
0.000285 0 3
0 0.000268 3
0.000143 0 5
0.996722 0.999465 5
0.000427 0 6
0.000142 0 6
0.000142 0.000268 8
0.000142 0 8
0.000142 0 8
0 0.000268 8
0 0.001338 8
0 0.00321 8
0.000142 0.000268 8
0.000142 0 8
0.000427 0.059658 8
0.000285 0 8
0 0.000268 8
0 0.000268 8
0.000142 0 8
0 0.000268 8
0 0.000268 8
0.000142 0 8
0 0.000535 8
0.759544 0.943553 8
0.000142 0 8
0 0.000268 8
0.000142 0 8
0 0.000268 8
0.000142 0 8
0 0.000268 8
0.00057 0.000803 8
0.000285 0 8
0 0.000268 10
0.001994 0.000535 10
0.000142 0 10
0.000142 0.000268 10
0 0.000268 10
0 0.000268 10
0 0.000268 11
0 0.000268 11
0.000142 0 12
0.000142 0 12
0.000142 0 13
0.000142 0 13
0.001567 0.000268 13
0 0.004013 13
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Table 3 (Continued)
Nucleotide change Protein change SNP accession number Frequency (EA) Frequency (AA) Exon
c.2276A>G Q759R 0.000142 0 14
c.2278G>C  D760H rs142947014 0.000142 0 14
c.2386A>G K796E 0 0.000268 14
c.2419A>G I807V  rs62287499 0.000427 0 14
c.2488A>T  T830S rs111500185 0.000285 0 15
c.2612A>C E871A  0.000142 0 15
c.2671A>G  I891V 0 0.000268 16
c.2882A>G  N961S rs191888688 0 0.000268 17
c.3187C>T  R1063C 0.000142 0 19
c.3221C>T T1074I rs146433145 0.000142 0 19
c.3343C>T  R1115C rs150054202 0 0.000268 21
c.3428A>G Q1143R  rs145414660 0 0.000268 21
c.3482G>A  R1161H rs139135683 0.000427 0 22
c.3511C>T  R1171C rs141684202 0 0.000268 22
c.3529C>T  R1177C 0 0.000268 22
c.3580C>T R1194W  0.000142 0 22
c.3584G>A S1195N  0.000142 0 22
c.3592C>T  R1198W rs113388242 0 0.000268 22
c.3617G>A R1206H rs112176450 0.000285 0 22
c.3649C>T  R1207C 0.000143 0 22
c.3650G>A R1217H  rs34086109 0 0.010433 22
c.3652G>A  G1217R rs138270117 0 0.000268 22
c.3686C>T  P1299L 0 0.000268 23
c.3688C>G  P1230A rs35629949 0.005842 0.001606 23
c.3701T>C  L1234P rs2230570 0.021937 0.080257 23
c.3743A>G K1248R 0.000142 0 23
c.3773A>G  N1258S rs73053766 0 0.001873 23
c.3935C>T S1312F  0 0.000268 24
c.3937A>G  T1313A rs144570332 0.000142 0.000803 24
c.3988A>G  M1330V rs112809828 0.000285 0 25
c.4067T>C M1356T rs144059151 0.000855 0 25
c.4068G>C  M1356I rs145975905 0.000285 0 25
c.4081A>G R1361G rs139793721 0 0.000268 25
c.4106C>T  P1369L rs142064428 0 0.000803 26
c.4184C>T T1395M  rs112441721 0 0.000268 27
c.4201G>A  G1401R rs149821418 0.000142 0.000803 27
c.4229A>C  E1410A rs141776790 0 0.000268 27
c.4259A>G E1420G 0  0.000268 27
c.4292C>T  S1431L 0.000142 0.000268 28
c.4300C>T P1434S  rs147696097 0.000142 0 28
c.4379G>A  R1460Q 0.000142 0 28
c.4399G>A  A1467T rs148270724 0.000142 0 29
c.4433C>T  T1478M rs141379472 0.000142 0 29
c.4454C>T  T1485M 0.000142 0 29
c.4486A>T T1496S 0 0.000268 29
c.4712C>T  A1571V rs144462594 0.000142 0 31
c.4772G>A R1591H  0.000142 0 31
i
e
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an total (NM 182917.3). Of note, 36 of them are located in
xon 8 and exon 22 (Table 3). To investigate coding variabil-
ty across the EIF4G1 gene we extracted the data from the
HLBI dataset and computed the average number of pairwise
mino acid differences between two randomly selected European-
merican haplotypes from the NHLBI dataset (Methods). On
verage two such EIF4G1 sequences diverge by 0.45 aminoacids.
2% of this variability (0.37 amino-acid differences) locates to exon
, where the A502V lies. 9.8% of this variability locates to exon
2 (0.098 amino-acid differences). Combined with the identiﬁca-
ion of six coding variants in exons 8 and 22 in African samples,
hese data are consistent with a more limited selective pressure
nd a higher sequence variability in this region of the EIF4G1
rotein.
These data, combined with the presence of the A502V in
he NHLBI population with 0.02% frequency and our failure to
dentify any PD mutation carrier in our familial cohort, are con-
istent with the interpretation that either EIF4G1 variants are
n extremely rare cause of familial PD in Caucasian cohorts, or
hat A502V is in fact a rare benign variant not involved in PD
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